Doxazosin Tablet
Product Images NDC 71335-2786

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-2786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 1)

Chemical structure of Doxazosin Mesylate, the active ingredient in Doxazosin 4 mg oral tablets. The diagram shows the molecular arrangement including rings, nitrogen atoms, and functional groups characteristic of Doxazosin Mesylate.*

FDA Label Image

Image (Image 2)

A data table presenting results from three studies measuring symptom score and maximum flow rate changes with doxazosin mesylate treatment versus placebo. The table includes mean baseline and mean change values, sample sizes for each group, and statistical significance indicators, accompanied by a bar graph showing symptom score and maximum flow rate changes for placebo, 4 mg, and 8 mg doxazosin mesylate groups in Study 2.*

FDA Label Image

1 (Image 3)

Two line graphs displaying clinical trial data for Doxazosin Mesylate. The top graph shows mean change in total symptom score from baseline over 14 weeks, with Doxazosin Mesylate reducing symptoms more than placebo. The bottom graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, with Doxazosin Mesylate demonstrating greater improvement compared to placebo. Both graphs include statistical significance markers and sample sizes (N=50 for Doxazosin Mesylate, N=47 for placebo).*

FDA Label Image

Label (Lbl713352786)

Label for Doxazosin Tablets, USP, containing 4 mg of Doxazosin Mesylate per tablet. The label indicates the package contains 100 tablets, is for prescription use only, and is repackaged by Bryant Ranch Prepack, Inc., with manufacturing by Piramal Pharma Limited. Storage instructions specify 20° to 25°C (68° to 77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.